Frailty is a multidimensional syndrome characterized by decreased physiological reserves, increasing vulnerability to adverse outcomes in older adults undergoing surgery. Perioperative optimization tailored to frailty status has emerged as a critical paradigm in geriatric surgical care, aiming to improve postoperative outcomes and reduce morbidity and mortality. This review summarizes current evidence and guidelines on frailty-informed perioperative management, highlighting epidemiology, pathophysiology, risk stratification, clinical assessment, and evidence-based interventions. Practical implications for clinicians are discussed, with a focus on integrating frailty assessment into surgical pathways and leveraging multidisciplinary strategies for optimized care.
The global demographic shift towards an aging population has brought frailty to the forefront of perioperative medicine. Older adults, especially those with frailty, face disproportionately high risks of postoperative complications, functional decline, and prolonged recovery. Conventional risk assessment models often inadequately capture the complexity of frailty, underscoring the necessity for frailty-informed approaches. Recent advances in geriatric assessment and multidisciplinary care pathways offer new opportunities to enhance perioperative outcomes for this vulnerable group.
Frailty affects approximately 10-20% of community-dwelling older adults and up to 50% in hospitalized populations. In the perioperative setting, prevalence estimates range from 15% to 56%, depending on the assessment tool and surgical cohort. Older adults with frailty are up to three times more likely to experience postoperative complications, including infections, delirium, and functional decline, compared to their robust counterparts. The economic burden is substantial, with increased healthcare utilization, prolonged hospital stays, and higher rates of institutionalization post-discharge. Notably, frailty is independently associated with increased 30-day and 1-year mortality after major surgery.
Frailty arises from cumulative deficits across multiple physiological systems, including musculoskeletal, cardiovascular, neuroendocrine, and immune pathways. The pathogenesis involves sarcopenia, chronic inflammation, impaired stress response, and dysregulation of homeostatic mechanisms. Surgical stress further exacerbates these vulnerabilities by triggering catabolic responses, fluid shifts, and immune activation. The resulting imbalance impairs wound healing, increases susceptibility to nosocomial infections, and compromises organ function, contributing to the cascade of adverse perioperative events observed in frail older adults.
Key risk factors for perioperative frailty include advanced age, polypharmacy, multimorbidity (especially cardiovascular, pulmonary, and cognitive disorders), malnutrition, and sedentary lifestyle. Social determinants such as social isolation, low socioeconomic status, and limited access to healthcare further elevate risk. Preoperative hospitalizations, prior falls, and poor mobility also predict increased frailty and perioperative complications. Recognition of these factors enables targeted screening and early intervention.
Frailty is characterized by unintentional weight loss, muscle weakness, slow gait speed, self-reported exhaustion, and low physical activity. Cognitive impairment, delirium, and functional dependence may also be prominent. In the perioperative context, frail patients often present atypically, with subtle or non-specific symptoms such as fatigue, confusion, or difficulty ambulating. Comprehensive geriatric assessment is essential to uncover these features and guide individualized care planning.
Multiple validated tools exist for frailty assessment. The Fried Frailty Phenotype and the Rockwood Clinical Frailty Scale (CFS) are widely used, providing both categorical and graded measures of frailty severity. The Edmonton Frail Scale, FRAIL questionnaire, and gait speed testing offer alternative approaches, each with distinct advantages in clinical workflow. Integrating frailty screening into preoperative evaluation enables risk stratification, shared decision-making, and tailored optimization strategies. Laboratory markers, such as low albumin and elevated C-reactive protein, may complement clinical assessment but are not standalone diagnostic criteria.
Frailty-informed perioperative optimization encompasses prehabilitation, medication review, nutritional support, and multidisciplinary care coordination. Prehabilitation programs, including aerobic and resistance exercise, have demonstrated improvements in functional capacity and postoperative recovery. Nutritional interventions focus on correcting deficits, optimizing protein intake, and addressing vitamin deficiencies. Comprehensive medication review targets polypharmacy and high-risk drugs, reducing the risk of adverse drug events and delirium. Early involvement of anesthesiologists, geriatricians, surgeons, and allied health professionals is essential for holistic care planning. Enhanced Recovery After Surgery (ERAS) protocols should be adapted to incorporate frailty considerations, such as minimizing fasting times, early mobilization, and delirium prevention strategies.
Emerging evidence supports the use of precision medicine approaches, including individualized risk prediction models and biomarker-guided interventions, to optimize outcomes in frail surgical patients. Digital health technologies, such as remote monitoring and tele-prehabilitation, are expanding access to preoperative optimization. Novel pharmacological agents targeting inflammation and muscle wasting are under investigation. Multicomponent interventions combining exercise, nutrition, and cognitive training have shown promise in reducing postoperative complications and enhancing functional recovery. Ongoing clinical trials are evaluating the efficacy of geriatric co-management models in high-risk surgical populations.
Recent guidelines from the American College of Surgeons, American Geriatrics Society, and European Society of Anaesthesiology emphasize routine frailty screening for older adults undergoing surgery. Multidisciplinary preoperative assessment, individualized risk-benefit discussions, and patient-centered decision-making are universally endorsed. Guideline recommendations support prehabilitation, nutritional optimization, and medication review as standard components of perioperative care. The implementation of frailty-informed ERAS protocols and the use of shared decision aids are encouraged to align surgical goals with patient values and preferences.
Frailty-informed perioperative optimization represents a paradigm shift in the surgical care of older adults, integrating multidimensional assessment, evidence-based interventions, and multidisciplinary collaboration. Recognizing frailty as a modifiable risk factor offers opportunities to improve surgical outcomes, reduce complications, and enhance quality of life for older patients. Ongoing research into novel therapies and care models will further refine best practices, supporting a patient-centered approach to aging and surgery.
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
healthy despite having advanced cancer.
3.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
4.
PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging
5.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
1.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
2.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
3.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
4.
Blood Donation Sustainability Through Behavioral Science
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation